|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Flexion Therapeutics
| | | Phone: | (781) 305-7777 | Fax: | (781) 202-3399 | Year Established: | 2007 | Ticker: | FLXN | Exchange: | NASDAQ | Main Contact: | Adam Muzikant, Ph.D., VP, Business Development | | Other Contacts: | David Arkowitz, CFO Mark Levine, General Counsel John Magee, VP, Sales Carolyn Beaty Scimemi, Esq., Chief Compliance Officer Dan Thornton, VP, Market Access Scott Kelley, M.D., CMO Christina Willwerth, BS, Senior VP, Program Management & Strategy Mike Clayman, MD, CEO & Co-Founder
| | Company Description | Flexion is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with OA, a type of degenerative arthritis. | |
|
|
|
|
|